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Background. Mycobacterium tuberculosis (Mtb) contributes to the pathogenesis of childhood acute community-acquired pneu-
monia in settings with a high tuberculosis burden. The incremental value of a repeated induced sputum (IS) sample, compared with 
a single IS or gastric aspirate (GA) sample, is not well known.
Methods. Two IS samples were obtained for Mtb culture from children enrolled as cases in the Pneumonia Etiology Research for 
Child Health (PERCH) study in South Africa. Nonstudy attending physicians requested GA if pulmonary tuberculosis was clinically 
suspected. We compared the Mtb yield of 2 IS samples to that of 1 IS sample and GA samples.
Results. Twenty-seven (3.0%) culture-confirmed pulmonary tuberculosis cases were identified among 906 children investigated 
with IS and GA samples for Mtb. Results from 2 IS samples were available for 719 children (79.4%). Of 12 culture-confirmed pulmo-
nary tuberculosis cases identified among children with ≥2 IS samples, 4 (33.3%) were negative at the first IS sample. In head-to-head 
comparisons among children with both GA and IS samples collected, the yield of 1 GA sample (8 of 427; 1.9%) was similar to that 
of 1 IS sample (5 of 427, 1.2%), and the yield of 2 GA samples (10 of 300; 3.3%) was similar to that of 2 IS samples (5 of 300; 1.7%). 
IS samples identified 8 (42.1%) of the 19 culture-confirmed pulmonary tuberculosis cases that were identified through submission 
of IS and GA samples.
Conclusions. A single IS sample underestimated the presence of Mtb in children hospitalized with severe or very severe pneu-
monia. Detection of Mtb is enhanced by combining 2 IS with GA sample collections in young children with acute severe pneumonia.
Keywords. child; tuberculosis; induced sputum; gastric aspirate; yield.
 
The optimal approach to diagnosis of childhood pulmonary 
tuberculosis remains to be determined, as existing methods lack 
sensitivity [1]. In settings with a high tuberculosis burden, up to 
15% of incident tuberculosis cases occur in children <14 years 
of age. Also, children <5 years of age are at higher risk of devel-
oping disease soon after infection with Mycobacterium tubercu-
losis (Mtb), most often manifest as pulmonary tuberculosis [2].
The microbiological diagnosis of pulmonary tuberculosis 
depends on detection of Mtb in respiratory samples obtained 
from a suspected case. Because children <5 years of age swal-
low rather than expectorate their sputum, the recommended 
approach to obtain respiratory secretions is by gastric aspirate 
(GA) or induced sputum (IS) sample collection [3]. The acidic 
environment in the stomach, however, may impair the viability 
of Mtb in GA samples, leading to lower yields compared with 
other respiratory samples [4]. Because primary pulmonary 
tuberculosis in children is generally noncavitating, results of 
microscopy of respiratory samples for acid-fast bacilli are often 
negative, and the sensitivity of culture of respiratory secretion 
samples among clinically diagnosed pulmonary tuberculosis 
cases is 7%–53% [5–8].
The feasibility of using IS sampling as an alternate to GA 
sampling for culturing Mtb was demonstrated in South African 
children <5 years of age hospitalized with clinically suspected 
pulmonary tuberculosis [9]. The same study reported that Mtb 
culture positivity from a single IS sample was similar to that 
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from 3 GA samples collected on consecutive days [9]. A more 
recent systematic literature review and meta-analysis estimated 
that 1–3 IS samples may identify 79% (95% confidence inter-
val [CI], 62%–92%) of culture-confirmed pediatric pulmonary 
tuberculosis cases identified through submission of comparator 
samples, including GA, pleural/lymph node culture, and naso-
pharyngeal aspirate samples [10].
Whereas pulmonary tuberculosis is generally considered a 
subacute or chronic illness [11–13], studies from high-burden 
countries have demonstrated that up to 8% of children hospi-
talized for acute community-acquired pneumonia also have 
culture-confirmed tuberculosis [14–16]. It remains unclear, 
however, whether pulmonary tuberculosis diagnosed in young 
children with severe acute community-acquired pneumonia 
represents Mtb as a cause of the pneumonia, or whether the 
pulmonary tuberculosis is an underlying immunosuppres-
sive condition predisposing children to acute bacterial or viral 
pneumonia [16].
The objective of the current study was to compare the yield of 
a single IS sample with that of 2 IS samples collected on separate 
days for culture of Mtb in children <5 years of age hospitalized 
with severe or very severe community-acquired pneumonia, 
in a setting with a high tuberculosis and human immunodefi-
ciency virus (HIV) burden. In addition, we compared the Mtb 
culture yield of 1 or 2 IS samples to the yield from 1, 2, or 3 GA 
samples obtained as part of standard care in these children.
METHODS
Cases
Children between 1 and 59 months of age hospitalized with 
World Health Organization (WHO)–defined severe or very 
severe pneumonia were recruited as part of the Pneumonia 
Etiology Research for Child Health (PERCH) study at the 
South African site, based at Chris Hani Baragwanath Academic 
Hospital, Soweto, Gauteng Province from 17 August 2011 to 
31 August 2013. Exclusion criteria for cases were hospitaliza-
tion within the previous 14 days, discharge as a PERCH case 
within the past 30 days, residence outside the study catchment 
area, or resolution of lower chest wall indrawing after bron-
chodilator therapy for those with wheezing. Further details 
about case identification and case definitions are provided 
elsewhere [17, 18].
IS samples were obtained for standard microbiological and 
Mtb culture in the children enrolled into the PERCH study, 
as well as polymerase chain reaction testing for multiple res-
piratory pathogens [19]. Whereas all the PERCH sites planned 
on collecting at least a single IS sample from the cases, it was 
decided a priori at the South African site to collect 2 IS samples 
on separate days to compare the yield of Mtb culture between 1 
and 2 IS samples. The second IS sample was obtained for study 
purposes only, and not as part of the standard of care. In 2011 
and 2012, the incidence (per 100 000 population) of a hospi-
tal-based diagnosis of culture-confirmed pulmonary tubercu-
losis in children <5 years of age resident in Soweto was 33 (95% 
CI, 26–41), and 185 (114–282) in HIV-positive children [20]. 
Because of the high tuberculosis burden at the South African 
site [20–23], clinicians admitting children with pneumonia 
frequently send 2 or 3 GA samples on separate days for Mtb 
culture. The vertical transmission prevalence of HIV infection 
from mother to child at the community level has been <3% in 
Gauteng Province since 2010, and the prevalence of HIV infec-
tion among children hospitalized at Chris Hani Baragwanath 
Academic Hospital was 19% in 2010/2011 [24, 25].
Procedures
Collection of IS samples was undertaken according to a 
standardized operating procedure used by all PERCH sites 
[26]. Trained study nurses obtained most of the IS samples, 
including those collected from children admitted to the high-
care ward, where the procedure was performed under super-
vision of the study clinician. Whenever possible, the first IS 
sample was obtained on the morning after enrollment, and 
the second obtained 24–72 hours after the initial sample. All 
IS sample collections were undertaken at least 2–3 hours after 
the child’s most recent meal or feeding. Temporary contrain-
dications to IS sample collection have been described else-
where [27].
IS samples were transported in a cooler box to the research 
laboratory for processing. The first sample was apportioned 
into 3 aliquots, 1 each for molecular testing, standard micro-
biological culture, and Mtb culture. The second IS sample was 
processed only for Mtb culture.
GA samples were collected after an overnight fast of ≥4 hours 
in a subset of PERCH cases with suspected Mtb infection, at the 
discretion of treating clinicians. Hospital procedure is to col-
lect 3 GA samples on 3 consecutive days, whenever possible, to 
evaluate young children with suspected pulmonary tuberculo-
sis. GA samples were collected into sterile containers without 
sodium bicarbonate buffer.
IS aliquots (designated for Mtb culture) and GA sam-
ples were sent to the National Health Laboratory Service 
Mycobacteriology Referral Laboratory, Braamfontein, 
Johannesburg. Samples were processed according to current 
guidelines by decontamination and digestion with sodium 
hydroxide/N-acetyl-cysteine [28]. Fluorescent microscopy for 
mycobacteria was conducted by auramine O staining of a por-
tion of the resuspended sputum/aspirate pellet. Samples were 
inoculated into mycobacterial growth indicator vials (MGIT; 
Becton-Dickinson) primed with growth supplement and anti-
biotics (PANTA™; Becton-Dickinson), which were incubated 
for a maximum of 42 days. Positive cultures were examined 
microscopically for acid-fast bacilli staining positive with 
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Ziehl-Neelsen stain, which were identified using a commer-
cially available line probe assay (HAIN GenoType MtbDRplus, 
HAIN Lifescience). Flag-positive MGIT vials that stained neg-
ative for acid-fast bacilli and lacked contaminants were reincu-
bated. Flag-positive MGIT vials that on staining demonstrated 
the presence of contaminants only were not processed further.
Children clinically suspected of having pulmonary tuber-
culosis were tested using tuberculin skin tests, administered 
according to the Mantoux method by nonresearch clinicians 
[29]. Tuberculin skin tests were interpreted 48–72 hours after 
intradermal inoculation of 0.5  mL of Tuberculin PPD RT 23 
(Statens Serum Institut), according to WHO guidelines [3].
Participant discharge diagnoses were abstracted from health 
records, and the hospital-based tuberculosis registry was 
reviewed to determine whether pulmonary tuberculosis had 
been diagnosed clinically by the attending clinician during the 
hospitalization. A case with clinically diagnosed tuberculosis 
was defined as a child who, regardless of tuberculin skin test 
response, had antituberculosis treatment started and was reg-
istered as having pulmonary tuberculosis during the PERCH 
hospitalization episode but had negative Mtb cultures. Children 
were designated as having culture-confirmed pulmonary tuber-
culosis if the IS, GA or other samples (endotracheal tube aspi-
rates and mycobacterial blood cultures) were culture positive 
for Mtb. Children with nonrespiratory specimens (eg, Mtb cul-
tured on blood) were deemed to have pulmonary tuberculosis 
if chest radiographic findings suggested pulmonary infection.
Analysis
We hypothesized that comprehensiveness of respiratory spec-
imen sampling to establish a diagnosis of pulmonary tubercu-
losis in acutely ill children may be influenced by the severity 
of illness and the degree of clinical suspicion of pulmonary 
tuberculosis. We conducted univariate and multivariate anal-
yses, using forward stepwise logistic regression, to determine 
which factors were associated with collection of 1 rather than 2 
IS samples, as well as factors associated with the treating clini-
cian’s decision to request GA sample collection. Factors associ-
ated with collection of 2 IS samples and those associated with 
GA sample collections were incorporated into the multivariate 
models if 2-sided P values were ≤0.20 at univariate analysis.
The yield of culture-confirmed Mtb was assessed in 7 com-
parisons: 1 versus 2 IS samples, 1 IS versus 1 GA sample, 1 IS 
versus 2 GA samples, 1 IS versus 3 GA samples, 2 IS versus 1 GA 
sample, 2 IS versus 2 GA samples, and 2 IS versus 3 GA sam-
ples. McNemar χ2 testing was performed to test the difference 
in yield between paired samples. Children who did not have 
IS or GA samples available for pairwise comparison according 
to the schema set out for comparison analyses outlined above, 
were excluded as appropriate. Occasionally, IS and GA samples 
were submitted for auramine O staining for mycobacteria and 
were not processed further for mycobacterial culture. Only IS 
or GA samples with available mycobacterial culture results were 
included in these analyses. Children with smear-positive, cul-
ture-negative samples were not considered confirmed pulmo-
nary tuberculosis cases [30].
Contamination of IS and GA samples with oropharyngeal 
bacterial or fungal organisms may inadvertently occur dur-
ing sample collection or processing and thus represents an 
actual operational scenario [31, 32]. Focusing our analysis only 
on instances where contaminated specimens did not occur 
would tend to overestimate the utility of IS and GA in pedi-
atric pulmonary tuberculosis diagnosis (by decreasing sample 
denominators while maintaining the numerator). Our analysis 
therefore included contaminated specimens in the denomina-
tors of IS and GA submitted to identify the culture-confirmed 
pulmonary tuberculosis cases. All analyses were performed 
using Stata version 13.0 (StataCorp, College Station, TX). 
Permissions to conduct the study, nested within the overarch-
ing PERCH study, were obtained from the institutional review 
boards of the University of the Witwatersrand and the Johns 
Hopkins Bloomberg School of Public Health.
RESULTS
Baseline Characteristics
Of 920 children enrolled as cases with WHO-defined severe 
(n = 622; 67.6%) or very severe (n = 298; 32.4%) pneumonia at 
the South African PERCH site, 906 (98.5%) had at least one IS 
or GA collected: 840 (92.7%) of these had at least one IS sam-
ple collected, with a second sample obtained in 785 (86.6%). 
Furthermore, 399 (44.0%) cases had ≥2 GA samples collected, 
on consecutive days in 228 (57.1%) of the 399, >1 day apart in 
122 (30.6%), and on the same day in 49 (12.3%). Of the 2782 
samples submitted to the laboratory, 157 (5.6%) did not undergo 
Mtb culture for varying reasons (75 culture not requested, 34 
lost in transit to the laboratory, 22 leaked, 22 unlabeled, 4 not 
processed owing to laboratory accidents). The first IS sample 
result was available in 799 children, of whom 328 (41.1%) had 
1 IS and ≥2 GA results, and 300 (37.5%) had 2 IS and ≥2 GA 
results (see Supplementary Figure 1).
Indicators of increasing pneumonia severity (central cyano-
sis at baseline and in-hospital death) were the 2 factors that, at 
multivariate analysis, were associated with omission of a second 
IS sample collection among children who had 1 IS sample sub-
mitted (data not shown). There were significant differences in 
baseline characteristics between children with and those with-
out a GA sample collected. At multivariate analysis, GA sample 
collection was positively associated with increasing age, dura-
tion of difficulty breathing, and positive tuberculin skin test 
result and negatively associated with nasal flaring and admin-
istration of antituberculosis treatment on the day of enrollment 
(Supplementary Table 1).
Of the 920 cases with pneumonia, 146 (15.9%) were iden-
tified either clinically or by culture confirmation as having 
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pulmonary tuberculosis, 119 (12.9%) were discharged with a 
clinical diagnosis of pulmonary tuberculosis without culture 
confirmation, and 27 (2.9%) had culture-confirmed tuberculo-
sis, including 1 with a diagnosis based on mycobacterial blood 
culture whose chest radiograph was abnormal and whose 2 IS 
cultures were negative (case 27 in Table 1). Twenty-five (92.6%) 
of the 27 children with culture-confirmed pulmonary tubercu-
losis were subjected to IS sample collections, and 19 (70.4%) 
had GA samples submitted. Similarly, 114 (95.8%) of the 119 
children with clinically diagnosed pulmonary tuberculosis had 
IS samples submitted, and 97 (81.5%) underwent GA sample 
collections. The crude yields of Mtb culture positivity in IS and 
GA samples among the children with clinically diagnosed and/
or culture-confirmed pulmonary tuberculosis were 9% (13 of 
139) and 14% (16 of 116), respectively. Forty-eight (32.9%) of 
the 146 children with pulmonary tuberculosis were HIV posi-
tive, 3 with culture-confirmed and 45 with clinically diagnosed 
pulmonary tuberculosis. HIV-positive children had a 6-fold 
greater odds (95% CI, 3.96–10.11) of having clinically diag-
nosed pulmonary tuberculosis but were just as likely to have 
culture-confirmed pulmonary tuberculosis as those who were 
HIV negative (odds ratio, 0.87; 95% CI, .17–2.94).
Auramine O staining was performed on samples from 896 
(98.9%) of 906 children with samples submitted for mycobacte-
rial culture. Eight (0.9%) had microscopic findings positive for 
mycobacteria, including 2 with culture-confirmed Mtb, 1 with 
clinically diagnosed pulmonary tuberculosis without culture 
confirmation, and 5 in whom a clinical diagnosis of pulmonary 
tuberculosis was not made.
Contamination of IS samples occurred in 47 (5.9%) and 64 (8.6%) 
of first and second IS samples, respectively, with higher contamina-
tion rates for the second IS samples (odds ratio, 1.50; 95% CI, 1.00–
2.27). Contamination rates ranged from 5.8% to 8.7% in GA samples, 
with no significant difference in these rates between specimens.
Yield of 2 Versus 1 IS Sample in Mtb Culture 
Twelve (1.7%) culture-confirmed pulmonary tuberculosis cases 
were identified among 719 children who had ≥2 IS samples with 
available culture results. Of the 12 Mtb culture-confirmed cases 
based on IS samples, 2 (16.7%) had positive cultures from both 
the first and second IS samples, 6 (50.0%) were detected only 
from the first sample, and 4 (33.3%) only from the second sam-
ple. The first IS sample identified 66.7% (95% CI, 34.9%–90.1%) 
of all culture-confirmed pulmonary tuberculosis cases detected 
with any IS sample, and the second IS sample identified 50.0% 
(95% CI, 21.1%–78.9%) (comparison 1 in Figure 1).
Yield of IS Versus GA Samples in Mtb Culture 
IS samples identified 8 (42.1%) of the 19 culture-confirmed 
pulmonary tuberculosis cases identified among patients who 
had both ≥1 IS and ≥1 GA sample collected (Table 1). In head-
to-head comparisons of single IS and GA samples and double 
IS and GA samples, GA samples alone identified a consistently 
greater proportion (6 of 11 [54.5%] for one GA sample, and 7 
of 12 [58.3%] for two GA samples) of culture-confirmed pul-
monary tuberculosis cases than did IS samples alone (3 of 11 
[27.3%] for one IS sample, and 2 of 12 [16.7%] for two IS sam-
ples) (comparisons 2 and 6 in Figure 1), although these findings 
Figure 1. Added value of induced sputum (IS) and gastric aspirate (GA) specimens in the detection of Mycobacterium tuberculosis (Mtb). Added value represents the 
number of cases positive for Mtb that were detected by submission of specimens/specimen groups and not by the comparator specimens/specimen groups. P values were 
determined with exact McNemar tests. Boxes with diagonal lines represent categories not applicable for comparison.
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were not statistically significant. In the comparison of cases 
with 2 IS and 2 GA samples, among whom there were 12 with 
culture-confirmed pulmonary tuberculosis (bolded cells in 
Table 1), the first IS sample identified 4 cases (33.3%), and the 
8 remaining cases (66.7%) were identified through GA sample 
culture, with or without culture of the second IS sample. The 
Mtb yields were greatest (3.7% and 4.0%, respectively) when 2 
GA samples were combined with 1 or 2 IS samples (compari-
sons 3 and 6 in Figure 1).
Culture-Confirmed Tuberculosis Identified in Children With No GA 
Samples Collected
Eight (29.6%) of the 27 culture-confirmed pulmonary tuber-
culosis cases occurred among children in whom no GA sam-
ples were collected, and who were therefore not included in the 
yield analyses involving GA samples, described above. Five chil-
dren had diagnoses based on IS samples alone, 2 had positive 
endotracheal endotracheal tube aspirate samples, and 1 had a 
positive Mtb blood culture (Table 1).
DISCUSSION
In this study, conducted in a high-burden tuberculosis setting 
with high HIV prevalence, we demonstrate that a second IS 
sample was able to identify 50% more pulmonary tuberculosis 
cases than would have been identified if relying on the submis-
sion of a single IS sample (comparison 1 in Figure 1). Among a 
subset of children who were investigated for pulmonary tuber-
culosis by ward clinicians through submission of GA samples, 
we found that GA samples had a higher yield of Mtb by cul-
ture than IS samples for diagnosing culture-confirmed pulmo-
nary tuberculosis in children <5 years of age hospitalized with 
WHO severe or very severe pneumonia. This contrasts with the 
findings of others that IS samples provide a higher yield of Mtb 
culture positivity in children with suspected pulmonary tuber-
culosis [9]. Furthermore, we showed that a single IS sample 
underestimates the prevalence of culture-confirmed pulmonary 
tuberculosis by 67%, compared with the combination of 2 IS 
and ≥2 GA samples.
The yield of a single IS sample was similar to that of the sec-
ond IS sample in our study (67% and 50%, respectively; com-
parison 1 in Figure 1), but both yields were greater than those 
observed in a large survey of the utility of IS sampling in the 
diagnosis of pediatric pulmonary tuberculosis in the ambula-
tory setting; in that study, the yields of the first and second IS 
samples were 38% and 27%, respectively [30].
Our study demonstrates a 3% prevalence of culture-con-
firmed Mtb in children hospitalized with WHO-defined severe 
or very severe pneumonia. This is lower than in previous South 
African studies, in which up to 8% of children hospitalized 
with acute severe community-acquired pneumonia, with or 
without hypoxia, had culture-confirmed pulmonary tuberculo-
sis [14, 15]. Significant advancements have been made in child 
healthcare policy in South Africa since the mid-1990s, which 
may explain why culture-confirmed Mtb is now less prevalent 
in young children with community-acquired pneumonia in our 
setting. Advances in prevention of mother-to-child transmission 
of HIV [33, 34] as well as earlier detection of pediatric HIV infec-
tion and scale-up of pediatric antiretroviral therapy [35], have 
contributed to declines in culture-confirmed Mtb in South Africa 
[21, 36]. Furthermore, there might be a lower force of infection 
of Mtb in South African children, with the ongoing decline in 
incidence of tuberculosis among adults since 2009 [36].
One or 2 IS specimens and 1–3 GA specimens submitted 
for Mtb culture were positive in 9% and 14% of the children 
with a clinical or culture-confirmed tuberculosis diagnosis in 
our study, which is toward the lower estimates of test positivity 
(7%–43%) in previous reports of children with clinically sus-
pected pulmonary tuberculosis [6, 37]. The extent of lung dis-
ease in children with classic pulmonary tuberculosis symptoms 
may be greater than that occurring in children with primary 
tuberculosis and concomitant bacterial pneumonia presenting 
with acute symptoms, making it difficult to draw direct compar-
isons about sample yields for pulmonary tuberculosis between 
studies. However, limited ability to establish a culture-con-
firmed diagnosis of pulmonary tuberculosis in young children 
reemphasizes the pressing need for more accurate diagnostic 
assays for childhood tuberculosis, which would also decrease 
the potential for misdiagnosing the condition and subjecting 
children to an unnecessary course of antituberculosis treatment.
Limitations of our study include the small number of cul-
ture-confirmed pulmonary tuberculosis cases in our cohort, the 
different manners in which the first and second IS samples were 
handled in the study, and the selective collection of GA sam-
ples. First IS samples were aliquoted for other microbiologic 
testing in addition to culture for Mtb, but the second IS samples 
were submitted for Mtb culture only. This could have reduced 
the sensitivity of the first IS sample in detecting Mtb because of 
the lower sample volume for Mtb culture, although the utility 
of the second sample in detecting Mtb may have been compro-
mised by the increased contamination rates observed in the 
second IS samples. Children from whom GA samples were col-
lected were significantly more likely to have clinical character-
istics associated with tuberculosis disease. If GA samples were 
routinely collected during the PERCH study, rather than just at 
the discretion of attending clinicians, the relative contributions 
of GA and IS samples to culture-confirmed pulmonary tuber-
culosis diagnosis in the cohort could have been more fully eval-
uated. Nevertheless, when limiting the comparison of GA and 
IS samples only to children in whom both specimen types were 
collected, the yield of Mtb culture positivity from GA samples 
was higher than that from IS samples.
In high-burdened settings of tuberculosis and HIV, children 
1–59 months of age presenting with acute community-acquired 
pneumonia have an appreciable burden of culture-confirmed 
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pulmonary tuberculosis that can be diagnosed through submis-
sion of GA and IS samples. Considering that the sensitivity of 
culture for childhood pulmonary tuberculosis is only 30%–40% 
across studies [38], it is possible that up to 10% of children hos-
pitalized with acute pneumonia in our setting have underlying 
pulmonary tuberculosis. The GA and IS sampling techniques 
complement one another, and a strategy in which 1 or 2 IS and 
2 GA samples are submitted on separate days may improve the 
diagnosis of pulmonary tuberculosis in such patients.
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